Health TrialsbyHealthPanel

Pilates Exercises on Balance, Fatigue and Quality of Life

ConditionRenal Transplantation
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age20-50
SponsorCairo University

About this trial

Fifty patients of both genders with age 20- 50 year old suffering from physical and functional limitations after renal transplantation surgeries participated in this study. The participants were randomly distributed into two groups equal in number. Group (A): 25 patients who received Pilates exercises 3 times per week in addition to conventional physical therapy program with medical care for 12 weeks while control group (group B) (n =25) who received conventional physical therapy program with medical care for 12 weeks.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

None

Disqualifiers

None

Trial design

Design model

Parallel

Treatments tested in this trial

  • Pilates Exercises

    Other intervention

    Pilates exercises consisted of three parts: warm-up, the main part, and relaxation. During the warm-up phase, exercises aimed at improving respiration and increasing the range of motion were performed. The main phase consisted of Pilates exercises for the center of force and strengthening of the articular, pelvic, trunk, and limb muscles by 13 exercises: Bridging, Hundred, Roll Up, One Leg Circle (both ways), Rocker with closed legs, Single Straight Leg Stretch, Double Leg Stretch, Spine Stretch Forward, Single Leg Kick, Side Kick up and down, Side Kick circles, Rest position (stretch and relaxation), and Curling. During the relaxation phase, stretching, relaxation, and breathing exercises were performed 3 times per week for 12 weeks.

  • Conventional physical therapy program

    Other intervention

    Conventional physical therapy program (aerobic walking program, low intensity strengthening Exs, stretching Exs) and medical care (analgesics, antibiotics, wound care) for 12 weeks.

Treatment groups

50 Participants
are divided into 2 treatment groups
Group A: Pilates exercises Plus Conventional physical therapy program.Experimental treatment 2 interventions
Group B: Conventional physical therapy programExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Borg Balance Scale

The Berg Balance Scale, possibly the most widely used balance-related measure, has gained popularity in clinical trials. It provides information about patients' balance-related abilities and can be used to assess improvement or worsening after rehabilitation. The BBS is a scale that includes scoring between 0 (not applicable) and 4 (normal performance) for the performance of 14 different tasks. Scores from 0 to 20 indicate a loss of balance, scores from 21 to 40 suggest an acceptable level of balance, and scores from 41 to 56 indicate good balance on this scale, which is examined across 56 points

Time frame
12 Weeks

Secondary outcomes

1

Modified Fatigue Impact Scale

Fatigue impact was assessed using the self-report Modified Fatigue Impact Scale (MFIS), which comprises a total score MFIS Total and three subscales (MFIS Physical, MFIS Cognitive and MFIS Psychosocial). Higher scores indicate more fatigue impact. The MFIS Total score (available range 0 - 84) was dichotomized at 38 to create two categories of participants, fatigued and non-fatigued

Time frame
12 Weeks
2

Kidney Disease Quality of Life self-report (KDQOL-SF)

This questionnaire is used to assess the QOL of patients with kidney disease, It contains twenty-four questions covering a wide range of domains of human functioning in daily, occupational and social life. It is a self-report measure, resulting from a subjective perception of one's health, functionality, and their QOL as directly related to having kidney disease. Each answer in the questionnaire is assigned a specific number of points. The scoring of answers in the KDQoL-SFTM questionnaire is carried out using a scale from 0 to 100 points. The higher the value, the higher the QOL, and the lower the value, the worse the QOL.

Time frame
12 Weeks

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Cairo University

Lead sponsor

Source ClinicalTrials.gov
Apply now